pI: 9.1327 |
Length (AA): 464 |
MW (Da): 51585 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
57 | 345 | 1puj (A) | 9 | 281 | 25.00 | 0 | 1 | 0.72 | -0.59 |
57 | 342 | 1puj (A) | 9 | 278 | 27.00 | 0 | 1 | 0.9 | -0.7 |
57 | 342 | 1puj (A) | 9 | 278 | 27.00 | 0 | 1 | 0.857279 | -0.27 |
57 | 343 | 1puj (A) | 9 | 279 | 25.00 | 0 | 1 | 0.802534 | -0.19 |
168 | 237 | 3iev (A) | 8 | 65 | 43.00 | 0.056 | 0.04 | 0.128762 | 0.8 |
290 | 458 | 4uos (A) | 3 | 171 | 11.00 | 0.0037 | 0.08 | 0.437624 | -0.45 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128449)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G41670 | P-loop containing nucleoside triphosphate hydrolases superfamily protein |
Babesia bovis | BBOV_III011080 | hypothetical protein |
Brugia malayi | Bm1_08080 | hypothetical protein |
Candida albicans | CaO19.2384 | similar to S. cerevisiae YMR097C |
Candida albicans | CaO19.9920 | similar to S. cerevisiae YMR097C |
Caenorhabditis elegans | CELE_Y67D2.4 | Protein Y67D2.4, isoform B |
Dictyostelium discoideum | DDB_G0268990 | hypothetical protein |
Drosophila melanogaster | Dmel_CG17141 | CG17141 gene product from transcript CG17141-RA |
Echinococcus granulosus | EgrG_000147100 | mitochondrial GTPase 1 |
Echinococcus multilocularis | EmuJ_000137000 | mitochondrial GTPase 1 |
Echinococcus multilocularis | EmuJ_000147100 | mitochondrial GTPase 1 |
Homo sapiens | ENSG00000148824 | mitochondrial ribosome-associated GTPase 1 |
Leishmania braziliensis | LbrM.34.5160 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_355180.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.35.5180 | hypothetical protein, conserved |
Leishmania major | LmjF.35.5210 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.5210 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_13564 | hypothetical protein |
Mus musculus | ENSMUSG00000039018 | mitochondrial GTPase 1 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_061080 | hypothetical protein |
Oryza sativa | 4350437 | Os11g0447300 |
Plasmodium berghei | PBANKA_1008300 | GTP-binding protein, putative |
Plasmodium falciparum | PF3D7_1436500 | GTP-binding protein, putative |
Plasmodium knowlesi | PKNH_0423100 | GTP-binding protein, putative |
Plasmodium vivax | PVX_084710 | GTP-binding protein, putative |
Plasmodium yoelii | PY02303 | Drosophila melanogaster CG17141 gene product, putative |
Saccharomyces cerevisiae | YMR097C | putative GTPase MTG1 |
Schistosoma japonicum | Sjp_0206620 | ko:K06948 GTP-binding protein, HSR1-related, putative |
Schistosoma mansoni | Smp_114160 | GTP-binding protein-related |
Trypanosoma brucei gambiense | Tbg972.9.5090 | GTP-binding protein, putative |
Trypanosoma brucei | Tb927.9.9150 | GTP-binding protein, putative |
Trypanosoma congolense | TcIL3000_9_3230 | GTP-binding protein, putative |
Trypanosoma cruzi | TcCLB.506883.100 | GTP-binding protein, putative |
Toxoplasma gondii | TGME49_219510 | GTP binding protein 7 isoform 2 family protein, putative |
Theileria parva | TP02_0027 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.0810 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.0810 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.0810 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb09.211.0810 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1008300 | Plasmodium berghei | Essential | plasmo |
TGME49_219510 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.